Skip to main content

ENGLISH · EVIDENCE OVERVIEW

AHK-Cu
evidence profile

Alanine-histidine-lysine copper complex. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

AHK-Cu: conceptual scientific illustration for Tissue / Repair Research
VISUAL GUIDE · AHK-Cu

Tissue / Repair Research

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

AHK-Cu is the alanine-histidine-lysine copper complex, not GHK-Cu. A 2007 study found effects in isolated human follicles and cultured cells; the reduction in apoptotic-cell count was not statistically significant. Ex vivo human tissue is not a clinical hair-regrowth trial.

01

ENTITY FACTS

What should readers identify first?

MOLECULEAHK-Cu
PHARMACOLOGYAlanine-histidine-lysine copper complex
PRIMECORE CLASSC
EVIDENCE GRADEE
RESEARCH TOPICTissue / Repair Research
LAST REVIEWED2026-08-30

What remains unknown?

Insufficient data in the current dataset

What limits these conclusions?

  • Human hair follicle outside the body ≠ human treatment trial; AHK-Cu ≠ GHK-Cu

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. Hair-follicle study · PMID 17703734
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is AHK-Cu?

AHK-Cu is described pharmacologically as Alanine-histidine-lysine copper complex. AHK-Cu is the alanine-histidine-lysine copper complex, not GHK-Cu. A 2007 study found effects in isolated human follicles and cultured cells; the reduction in apoptotic-cell count was not statistically significant. Ex vivo human tissue is not a clinical hair-regrowth trial.

Does AHK-Cu have strong evidence?

PrimeCoreBio records Evidence Grade E. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is AHK-Cu approved everywhere?

No global conclusion should be inferred. PrimeCore Class C must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice